336 related articles for article (PubMed ID: 12818831)
1. Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Morimoto M; Shirato K; Sugimori K; Kokawa A; Tomita N; Saito T; Imada T; Tanaka N; Nozawa A; Numata K; Tanaka K
AJR Am J Roentgenol; 2003 Jul; 181(1):65-9. PubMed ID: 12818831
[TBL] [Abstract][Full Text] [Related]
2. Using contrast-enhanced sonography to assess the effectiveness of transcatheter arterial embolization for hepatocellular carcinoma.
Numata K; Tanaka K; Kiba T; Saito S; Isozaki T; Hara K; Morimoto M; Sekihara H; Yonezawa H; Kubota T
AJR Am J Roentgenol; 2001 May; 176(5):1199-205. PubMed ID: 11312181
[TBL] [Abstract][Full Text] [Related]
3. Use of carbon dioxide microbubble-enhanced sonographic angiography for transcatheter arterial chemoembolization of hepatocellular carcinoma.
Hashimoto M; Watanabe O; Hirano Y; Kato K; Watarai J
AJR Am J Roentgenol; 1997 Nov; 169(5):1307-10. PubMed ID: 9353447
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography.
Minami Y; Kudo M; Kawasaki T; Kitano M; Chung H; Maekawa K; Shiozaki H
AJR Am J Roentgenol; 2003 Mar; 180(3):703-8. PubMed ID: 12591679
[TBL] [Abstract][Full Text] [Related]
5. Evaluation using contrast-enhanced harmonic gray scale sonography after radio frequency ablation of small hepatocellular carcinoma: sonographic-histopathologic correlation.
Morimoto M; Nozawa A; Numata K; Shirato K; Sugimori K; Kokawa A; Tomita N; Saitou T; Nakatani Y; Imada T; Tanaka K
J Ultrasound Med; 2005 Mar; 24(3):273-83. PubMed ID: 15723840
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma.
Numata K; Isozaki T; Ozawa Y; Sakaguchi T; Kiba T; Kubota T; Ito A; Sugimori K; Shirato K; Morimoto M; Tanaka K
AJR Am J Roentgenol; 2003 Jan; 180(1):143-9. PubMed ID: 12490493
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma.
Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Maekawa K
AJR Am J Roentgenol; 2001 Mar; 176(3):661-6. PubMed ID: 11222201
[TBL] [Abstract][Full Text] [Related]
8. Power Doppler sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma.
Sumi S; Yamashita Y; Mitsuzaki K; Yamamoto H; Urata J; Nishiharu T; Takahashi M
AJR Am J Roentgenol; 1999 Jan; 172(1):67-71. PubMed ID: 9888742
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT.
Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Chung H; Kawasaki T; Maekawa K
Radiology; 2001 Dec; 221(3):721-30. PubMed ID: 11719668
[TBL] [Abstract][Full Text] [Related]
10. Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography.
Xia Y; Kudo M; Minami Y; Hatanaka K; Ueshima K; Chung H; Hagiwara S; Inoue T; Ishikawa E; Kitai S; Takahashi S; Tatsumi C; Ueda T; Hayaishi S; Maekawa K
Oncology; 2008; 75 Suppl 1():99-105. PubMed ID: 19092278
[TBL] [Abstract][Full Text] [Related]
11. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
[TBL] [Abstract][Full Text] [Related]
12. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of transcatheter arterial chemoembolization on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic power Doppler ultrasound.
Cioni D; Lencioni R; Bartolozzi C
Eur Radiol; 2000; 10(10):1570-5. PubMed ID: 11044926
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic response evaluation of malignant hepatic masses treated by interventional procedures with contrast-enhanced agent detection imaging.
Youk JH; Lee JM; Kim CS
J Ultrasound Med; 2003 Sep; 22(9):911-20. PubMed ID: 14510262
[TBL] [Abstract][Full Text] [Related]
15. 1.5 Harmonic Imaging Sonography with microbubble contrast agent improves characterization of hepatocellular carcinoma.
Yamamoto K; Shiraki K; Nakanishi S; Fuke H; Nakano T; Hashimoto A; Shimizu A; Hamataki T
World J Gastroenterol; 2005 Sep; 11(36):5607-13. PubMed ID: 16237752
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
[TBL] [Abstract][Full Text] [Related]
17. Sono-hepatic-arteriography (Sono-HA) in the assessment of hepatocellular carcinoma in patients undergoing transcatheter arterial chemoembolization (TACE).
Schacherer D; Girlich C; Zorger N; Wiest R; Schoelmerich J; Feuerbach S; Jung EM
Ultraschall Med; 2010 Jun; 31(3):270-5. PubMed ID: 20408118
[TBL] [Abstract][Full Text] [Related]
18. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography.
Numata K; Morimoto M; Ogura T; Sugimori K; Takebayashi S; Okada M; Tanaka K
J Ultrasound Med; 2008 Mar; 27(3):395-406. PubMed ID: 18314518
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.
Wen YL; Kudo M; Zheng RQ; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
AJR Am J Roentgenol; 2003 Jul; 181(1):57-63. PubMed ID: 12818830
[TBL] [Abstract][Full Text] [Related]
20. Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation.
Lim HS; Jeong YY; Kang HK; Kim JK; Park JG
AJR Am J Roentgenol; 2006 Oct; 187(4):W341-9. PubMed ID: 16985104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
